Your browser doesn't support javascript.
loading
Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial.
Lenze, Eric J; Mulsant, Benoit H; Blumberger, Daniel M; Karp, Jordan F; Newcomer, John W; Anderson, Stewart J; Dew, Mary Amanda; Butters, Meryl A; Stack, Jacqueline A; Begley, Amy E; Reynolds, Charles F.
Affiliation
  • Lenze EJ; Washington University School of Medicine, St Louis, MO, USA. Electronic address: lenzee@psychiatry.wustl.edu.
  • Mulsant BH; Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
  • Blumberger DM; Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
  • Karp JF; University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Newcomer JW; Charles E Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, USA.
  • Anderson SJ; University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, USA.
  • Dew MA; University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Butters MA; University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Stack JA; University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Begley AE; University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Reynolds CF; University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, USA.
Lancet ; 386(10011): 2404-12, 2015 Dec 12.
Article in En | MEDLINE | ID: mdl-26423182

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Depressive Disorder, Treatment-Resistant / Aripiprazole / Antidepressive Agents Type of study: Clinical_trials / Etiology_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Lancet Year: 2015 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Depressive Disorder, Treatment-Resistant / Aripiprazole / Antidepressive Agents Type of study: Clinical_trials / Etiology_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Lancet Year: 2015 Type: Article